PATENT CLAIM ANALYSIS

Application Number: 16000467
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "282000"]

Abstract:
The invention relates to novel strategies for the treatment of cancer patients based on a combination of an opioid receptor agonist and an anticancer compound.

Claim (Index 21):
A method for administering a combination of an opioid receptor agonist and at least one anticancer agent to a patient, wherein the method comprises the steps of:\n (a) administering said opioid receptor agonist to the patient in one or more doses to establish a therapeutically effective plasma level for a period of at least four weeks, and (b) administering to the patient at least one anticancer agent that is selected from the group consisting of chemotherapeutical agents, cytotoxic agents, cytostatic agents, immunotoxic agents and radiotherapy, to establish a period with a therapeutically effective plasma level, and (c) wherein said periods of a) and b) overlap; and\n whereby said at least one anticancer agent and said opioid receptor agonist are administered successively with the opioid receptor agonist being administered first.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 94.0
- Lexical Diversity: 1.08333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['10835511', '13338809', '15920486', '13907035', '14427426']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8006474161288915
- 35 USC 102 Novelty (BERT): 0.5165031064871901
- Combined Prediction Score: 0.7722329851647214
- Mean Citation Score: 292.329026
- Max Citation Score: 308.32446
- Similarity Product: 217.5895089016557

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test